 Home > Active Ingredient News > Immunology News > Ann Rheum Dis: TNF inhibitor treatment in JIA children increases psoriasis incidence

Ann Rheum Dis: TNF inhibitor treatment in JIA children increases psoriasis incidence

 Last Update: 2022-03-02
 Source: Internet
 Author: User

Tags

triamcinolone acetonide psoriasis

neurodegenerative disease symptoms

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Tumor necrosis factor inhibitors (TNFi) have been approved for the treatment of juvenile idiopathic arthritis (JIA) in children

child

Using data from the Childhood Arthritis and Rheumatology Research Consortium (CARRA) registry, researchers aimed to explore the relationship between tumor necrosis factor inhibitor (TNFi) therapy and early childhood.

The researchers obtained patient data from the CARRA registry

diagnosis

The study included 8225 patients with a median follow-up of 3.

CONCLUSIONS: In a large prospective cohort of patients with JIA, we observed a nearly three-fold increase in psoriasis risk following TNFi treatment

In a large prospective cohort of JIA patients, the researchers observed a nearly three-fold increase in psoriasis risk following TNFi treatment

Original source:

Yongdong Zhao, et al.

Psoriasis rate is increased by the exposure to TNF inhibition in children with

JIA

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.